199 related articles for article (PubMed ID: 11694096)
41. Immunohistochemical diagnosis of systemic bovine zygomycosis by murine monoclonal antibodies.
Jensen HE; Aalbaek B; Lind P; Krogh HV
Vet Pathol; 1996 Mar; 33(2):176-83. PubMed ID: 8801711
[TBL] [Abstract][Full Text] [Related]
42. The role of iron and iron chelators in zygomycosis.
Symeonidis AS
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():26-32. PubMed ID: 19754753
[TBL] [Abstract][Full Text] [Related]
43. The ecology of the Zygomycetes and its impact on environmental exposure.
Richardson M
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():2-9. PubMed ID: 19754749
[TBL] [Abstract][Full Text] [Related]
44. Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis.
Chamilos G; Lewis RE; Hu J; Xiao L; Zal T; Gilliet M; Halder G; Kontoyiannis DP
Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9367-72. PubMed ID: 18583479
[TBL] [Abstract][Full Text] [Related]
45. In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method.
Singh J; Rimek D; Kappe R
Mycoses; 2005 Jul; 48(4):246-50. PubMed ID: 15982206
[TBL] [Abstract][Full Text] [Related]
46. Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.
Ibrahim AS; Bowman JC; Avanessian V; Brown K; Spellberg B; Edwards JE; Douglas CM
Antimicrob Agents Chemother; 2005 Feb; 49(2):721-7. PubMed ID: 15673756
[TBL] [Abstract][Full Text] [Related]
47. Hospital Outbreak of Pulmonary and Cutaneous Zygomycosis due to Contaminated Linen Items From Substandard Laundry.
Cheng VCC; Chen JHK; Wong SCY; Leung SSM; So SYC; Lung DC; Lee WM; Trendell-Smith NJ; Chan WM; Ng D; To L; Lie AKW; Yuen KY
Clin Infect Dis; 2016 Mar; 62(6):714-721. PubMed ID: 26668339
[TBL] [Abstract][Full Text] [Related]
48. Posaconazole prophylaxis in experimental systemic zygomycosis.
Barchiesi F; Spreghini E; Santinelli A; Fothergill AW; Pisa E; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2007 Jan; 51(1):73-7. PubMed ID: 17060525
[TBL] [Abstract][Full Text] [Related]
49. Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B.
Vazquez L; Mateos JJ; Sanz-Rodriguez C; Perez E; Caballero D; San Miguel JF
Haematologica; 2005 Dec; 90(12 Suppl):ECR39. PubMed ID: 16464754
[TBL] [Abstract][Full Text] [Related]
50. Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism.
Petraitis V; Petraitiene R; Antachopoulos C; Hughes JE; Cotton MP; Kasai M; Harrington S; Gamaletsou MN; Bacher JD; Kontoyiannis DP; Roilides E; Walsh TJ
Med Mycol; 2013 Jan; 51(1):72-82. PubMed ID: 22686246
[TBL] [Abstract][Full Text] [Related]
51. Rhizoferrin: a complexone type siderophore of the Mucorales and entomophthorales (Zygomycetes).
Thieken A; Winkelmann G
FEMS Microbiol Lett; 1992 Jul; 73(1-2):37-41. PubMed ID: 1387861
[TBL] [Abstract][Full Text] [Related]
52. Clinical presentation of zygomycosis.
Mantadakis E; Samonis G
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():15-20. PubMed ID: 19754751
[TBL] [Abstract][Full Text] [Related]
53. Primary renal zygomycosis due to Rhizopus oryzae.
Yu J; Li RY
Med Mycol; 2006 Aug; 44(5):461-6. PubMed ID: 16882613
[TBL] [Abstract][Full Text] [Related]
54. Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B.
Van Cutsem J; Van Gerven F; Fransen J; Janssen PA
Chemotherapy; 1989; 35(4):267-72. PubMed ID: 2548818
[TBL] [Abstract][Full Text] [Related]
55. Crossed immunoelectrophoresis of fungal antigens in tissues as a means of diagnosing systemic aspergillosis and zygomycosis in cattle.
Jensen HE
Vet Res Commun; 1993; 17(4):267-75. PubMed ID: 8146952
[TBL] [Abstract][Full Text] [Related]
56. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.
Kontoyiannis DP; Lionakis MS; Lewis RE; Chamilos G; Healy M; Perego C; Safdar A; Kantarjian H; Champlin R; Walsh TJ; Raad II
J Infect Dis; 2005 Apr; 191(8):1350-60. PubMed ID: 15776383
[TBL] [Abstract][Full Text] [Related]
57. Relationship between metabolism and biomass of medically important zygomycetes.
Antachopoulos C; Meletiadis J; Roilides E; Sein T; Sutton DA; Wickes BL; Rinaldi MG; Merz WG; Shea YR; Walsh TJ
Med Mycol; 2006 Aug; 44(5):429-38. PubMed ID: 16882609
[TBL] [Abstract][Full Text] [Related]
58. Enzyme immunohistochemistry with mono- and polyclonal antibodies in the pathological diagnosis of systemic bovine mycoses.
Jensen HE; Aalbaek B; Lind P; Frandsen PL; Krogh HV; Stynen D
APMIS; 1993 Jul; 101(7):505-16. PubMed ID: 8398091
[TBL] [Abstract][Full Text] [Related]
59. Antigenic characterization of some potentially pathogenic mucoraceous fungi.
Hessian PA; Smith JM
Sabouraudia; 1982 Sep; 20(3):209-16. PubMed ID: 6182620
[TBL] [Abstract][Full Text] [Related]
60. Thyroid involvement in disseminated zygomycosis by Cunninghamella bertholletiae: 2 cases and literature review.
Mayayo E; Klock C; Goldani L
Int J Surg Pathol; 2011 Feb; 19(1):75-9. PubMed ID: 19168908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
